Achim Huber
Direttore/Membro del Consiglio presso Vitane Biologics Pvt Ltd.
Profilo
Achim Huber is currently the Director at Vitane Biologics Pvt Ltd.
He was previously the Managing Director at Vitane Pharma GmbH.
Posizioni attive di Achim Huber
| Società | Posizione | Inizio |
|---|---|---|
Vitane Biologics Pvt Ltd.
 Vitane Biologics Pvt Ltd. Pharmaceuticals: MajorHealth Technology Vitane Biologics Pvt Ltd is a biopharmaceutical company based in Hyderabad, India. The private company was founded in 2006 by Jeetendra K Ambulge. Vitane Biologics provides end-to-end solutions for the development, technology transfer, and manufacture of biopharmaceuticals. The Indian company has state-of-the-art R & D and cGMP manufacturing facilities to handle both microbial and cell culture-based technology platforms. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Achim Huber
| Società | Posizione | Fine |
|---|---|---|
Vitane Pharma GmbH
 Vitane Pharma GmbH Wholesale DistributorsDistribution Services Vitane Pharma GmbH wholesales pharmaceutical goods. The private company is based in Wolfratshausen, Germany. The CEO of the German company is Norbert Kübler. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Vitane Pharma GmbH
Vitane Pharma GmbH Wholesale DistributorsDistribution Services Vitane Pharma GmbH wholesales pharmaceutical goods. The private company is based in Wolfratshausen, Germany. The CEO of the German company is Norbert Kübler. | Distribution Services |
Vitane Biologics Pvt Ltd.
Vitane Biologics Pvt Ltd. Pharmaceuticals: MajorHealth Technology Vitane Biologics Pvt Ltd is a biopharmaceutical company based in Hyderabad, India. The private company was founded in 2006 by Jeetendra K Ambulge. Vitane Biologics provides end-to-end solutions for the development, technology transfer, and manufacture of biopharmaceuticals. The Indian company has state-of-the-art R & D and cGMP manufacturing facilities to handle both microbial and cell culture-based technology platforms. | Health Technology |
- Borsa valori
- Insiders
- Achim Huber
